跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
TRANAMEF tranylcypromine (as sulfate) 10 mg tablet bottle
Approved
STANDARD
TRANAMEF tranylcypromine (as sulfate) 10 mg tablet bottle
Glenmark Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
c5c5289f1b1b7d55
Company
Glenmark Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
c5c5289f1b1b7d55
Product Name
TRANAMEF tranylcypromine (as sulfate) 10 mg tablet bottle
Artg Id
444810
Artg Name
TRANAMEF tranylcypromine (as sulfate) 10 mg tablet bottle
Sponsor
Glenmark Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/glenmark-pharmaceuticals-australia-pty-limited
Artg Date
2025-04-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
c5c5289f1b1b7d55
Type
Standard
Back to TGA Approvals
TRANAMEF tranylcypromine (as sulfate) 10 mg tablet bottle - TGA Drug Approval Details
